145 related articles for article (PubMed ID: 2182246)
1. Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease.
Rowe GG; Folts JD
Clin Cardiol; 1990 Mar; 13(3):165-70. PubMed ID: 2182246
[TBL] [Abstract][Full Text] [Related]
2. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Shalaev SV
Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
[No Abstract] [Full Text] [Related]
3. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
4. Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
Patrono C
Eur Heart J; 1986 Jun; 7(6):454-9. PubMed ID: 3525167
[No Abstract] [Full Text] [Related]
5. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Turpie AG
Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
[TBL] [Abstract][Full Text] [Related]
6. Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin.
Josa M; Lie JT; Bianco RL; Kaye MP
Am J Cardiol; 1981 Jun; 47(6):1248-54. PubMed ID: 6972158
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
Barnathan ES; Schwartz JS; Taylor L; Laskey WK; Kleaveland JP; Kussmaul WG; Hirshfeld JW
Circulation; 1987 Jul; 76(1):125-34. PubMed ID: 2954724
[TBL] [Abstract][Full Text] [Related]
8. A trial of dipyridamole and aspirin in the prevention of smoking-induced changes in platelets and endothelium in men with coronary artery disease.
Davis JW; Hartman CR; Shelton L; Ruttinger HA
Am J Cardiol; 1989 Jun; 63(20):1450-4. PubMed ID: 2524959
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
[TBL] [Abstract][Full Text] [Related]
10. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy in coronary artery disease: review and update of efficacy studies.
Tisdale JE
Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S8-16. PubMed ID: 9784797
[TBL] [Abstract][Full Text] [Related]
12. Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole, and thrombolysis.
Moschos CB; Lahiri K; Lyons M; Weisse AB; Oldewurtel HA; Regan TJ
Am Heart J; 1973 Jul; 86(1):61-8. PubMed ID: 4268306
[No Abstract] [Full Text] [Related]
13. Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition.
Schmidt U; Han RO; DiSalvo TG; Guerrero JL; Gold HK; Zapol WM; Bloch KD; Semigran MJ
J Am Coll Cardiol; 2001 Jun; 37(7):1981-8. PubMed ID: 11401142
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Klimt CR; Doub PH; Doub NH
Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
16. Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm-infected, and embolized heartworm-infected dogs.
Boudreaux MK; Dillon AR; Ravis WR; Sartin EA; Spano JS
Am J Vet Res; 1991 Dec; 52(12):1992-9. PubMed ID: 1789513
[TBL] [Abstract][Full Text] [Related]
17. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
[TBL] [Abstract][Full Text] [Related]
18. Aspirin and other antiplatelet drugs in the prophylaxis of thrombosis.
Webster J; Douglas AS
Blood Rev; 1987 Mar; 1(1):9-20. PubMed ID: 3332089
[TBL] [Abstract][Full Text] [Related]
19. Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease.
Crown N; Mysak T
Am J Health Syst Pharm; 2010 May; 67(9):728-33. PubMed ID: 20410547
[TBL] [Abstract][Full Text] [Related]
20. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
Al-Mondhiry H; Pierce WS; Pennock JL
J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
